Skip to main content

Longeveron Inc.

LGVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001721484

No open-market purchases or sales by Longeveron Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $3.35M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Longeveron Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of LGVN: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders2529+4
Shares667.5K1.04M+377.3K (+56.5%)
Value$868.1K$783.1K−$84.9K (−9.8%)

New holders (8)

Institutions that held Longeveron Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to LGVN in Q3 2025
InstitutionSharesValue% of portfolio
Renaissance Technologies LLC56,600$42.5K0.00%
Jane Street Group, LLC43,942$33.0K0.00%
Hamilton Point Investment Advisors, LLC22,446$16.8K0.00%
HRT Financial LP17,257$12.0K0.00%
Virtu Financial LLC14,434$11.0K0.00%
Two Sigma Securities, LLC12,835$9.63K0.00%
Moneta Group Investment Advisors LLC12,000$9.00K0.00%
Cornerstone Planning Group LLC1,125$9420.00%

Sold out (4)

Institutions that held Longeveron Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of LGVN in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Citadel Advisors LLC93,653$121.7K
XTX Topco Ltd48,003$62.4K
The PNC Financial Services Group, Inc.17$22
Caitong International Asset Management Co., Ltd1$1